Skip to main content

Peer Review reports

From: Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

Original Submission
24 May 2022 Submitted Original manuscript
22 Jul 2022 Reviewed Reviewer Report - Massimiliano Lanzafame
4 Aug 2022 Reviewed Reviewer Report - Juan Pasquau
4 Sep 2022 Author responded Author comments - Franco Maggiolo
Resubmission - Version 2
4 Sep 2022 Submitted Manuscript version 2
12 Sep 2022 Author responded Author comments - Franco Maggiolo
Resubmission - Version 3
12 Sep 2022 Submitted Manuscript version 3
14 Sep 2022 Author responded Author comments - Franco Maggiolo
Resubmission - Version 4
14 Sep 2022 Submitted Manuscript version 4
Publishing
4 Oct 2022 Editorially accepted
12 Oct 2022 Article published 10.1186/s12879-022-07769-6

You can find further information about peer review here.

Back to article page